CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 1b, Multicenter, Randomized, Placebo-controlled, Observer-blinded, Dose-escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05762393
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-29T15:20:05.594268+00:00
Published At: 2026-04-29T00:00:00+00:00
Record Updated At: 2026-04-29
Results Posted At: 2026-04-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Schistosomiasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-29"
protocolSection.identificationModule.nctId: "NCT05762393"
protocolSection.identificationModule.officialTitle: "A Phase 1b, Multicenter, Randomized, Placebo-controlled, Observer-blinded, Dose-escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield\u00ae) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-04-29"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.